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Abstract: Despite the attractiveness of breath analysis as a non-invasive means to retrieve relevant
metabolic information, its introduction into routine clinical practice remains a challenge. Among all the
different analytical techniques available to interrogate exhaled breath, secondary electrospray ionization
high-resolution mass spectrometry (SESI-HRMS) offers a number of advantages (e.g., real-time, yet wide,
metabolome coverage) that makes it ideal for untargeted and targeted studies. However, so far, SESI-
HRMS has relied mostly on lab-built prototypes, making it difficult to standardize breath sampling and
subsequent analysis, hence preventing further developments such as multi-center clinical studies. To
address this issue, we present here a number of new developments. In particular, we have characterized a
new SESI interface featuring real-time readout of critical exhalation parameters such as CO2, exhalation
flow rate, and exhaled volume. Four healthy subjects provided breath specimens over a period of 1 month
to characterize the stability of the SESI-HRMS system. A first assessment of the repeatability of the
system using a gas standard revealed a coefficient of variation (CV) of 2.9%. Three classes of aldehydes,
namely 4-hydroxy-2-alkenals, 2-alkenals and 4-hydroxy-2,6-alkedienals-hypothesized to be markers of
oxidative stress-were chosen as representative metabolites of interest to evaluate the repeatability and
reproducibility of this breath analysis analytical platform. Median and interquartile ranges (IQRs) of
CVs for CO2, exhalation flow rate, and exhaled volume were 3.2% (1.5%), 3.1% (1.9%), and 5.0% (4.6%),
respectively. Despite the high repeatability observed for these parameters, we observed a systematic
decay in the signal during repeated measurements for the shorter fatty aldehydes, which eventually
reached a steady state after three/four repeated exhalations. In contrast, longer fatty aldehydes showed
a steady behavior, independent of the number of repeated exhalation maneuvers. We hypothesize that
this highly molecule-specific and individual-independent behavior may be explained by the fact that
shorter aldehydes (with higher estimated blood-to-air partition coefficients; approaching 100) mainly
get exchanged in the airways of the respiratory system, whereas the longer aldehydes (with smaller
estimated blood-to-air partition coefficients; approaching 10) are thought to exchange mostly in the
alveoli. Exclusion of the first three exhalations from the analysis led to a median CV (IQR) of 6.7 %
(5.5 %) for the said classes of aldehydes. We found that such intra-subject variability is in general much
lower than inter-subject variability (median relative differences between subjects 48.2%), suggesting that
the system is suitable to capture such differences. No batch effect due to sampling date was observed,
overall suggesting that the intra-subject variability measured for these series of aldehydes was biological
rather than technical. High correlations found among the series of aldehydes support this notion. Finally,
recommendations for breath sampling and analysis for SESI-HRMS users are provided with the aim of
harmonizing procedures and improving future inter-laboratory comparisons. Graphical abstract.
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Abstract
Despite the attractiveness of breath analysis as a non-invasive means to retrieve relevant metabolic information, its introduction
into routine clinical practice remains a challenge. Among all the different analytical techniques available to interrogate exhaled
breath, secondary electrospray ionization high-resolution mass spectrometry (SESI-HRMS) offers a number of advantages (e.g.,
real-time, yet wide, metabolome coverage) that makes it ideal for untargeted and targeted studies. However, so far, SESI-HRMS
has relied mostly on lab-built prototypes, making it difficult to standardize breath sampling and subsequent analysis, hence
preventing further developments such as multi-center clinical studies. To address this issue, we present here a number of new
developments. In particular, we have characterized a new SESI interface featuring real-time readout of critical exhalation
parameters such as CO2, exhalation flow rate, and exhaled volume. Four healthy subjects provided breath specimens over a
period of 1 month to characterize the stability of the SESI-HRMS system. A first assessment of the repeatability of the system
using a gas standard revealed a coefficient of variation (CV) of 2.9%. Three classes of aldehydes, namely 4-hydroxy-2-alkenals,
2-alkenals and 4-hydroxy-2,6-alkedienals―hypothesized to be markers of oxidative stress―were chosen as representative
metabolites of interest to evaluate the repeatability and reproducibility of this breath analysis analytical platform. Median and
interquartile ranges (IQRs) of CVs for CO2, exhalation flow rate, and exhaled volume were 3.2% (1.5%), 3.1% (1.9%), and 5.0%
(4.6%), respectively. Despite the high repeatability observed for these parameters, we observed a systematic decay in the signal
during repeated measurements for the shorter fatty aldehydes, which eventually reached a steady state after three/four repeated
exhalations. In contrast, longer fatty aldehydes showed a steady behavior, independent of the number of repeated exhalation
maneuvers. We hypothesize that this highly molecule-specific and individual-independent behavior may be explained by the fact
that shorter aldehydes (with higher estimated blood-to-air partition coefficients; approaching 100) mainly get exchanged in the
airways of the respiratory system, whereas the longer aldehydes (with smaller estimated blood-to-air partition coefficients;
approaching 10) are thought to exchange mostly in the alveoli. Exclusion of the first three exhalations from the analysis led to
a median CV (IQR) of 6.7 % (5.5 %) for the said classes of aldehydes. We found that such intra-subject variability is in general
much lower than inter-subject variability (median relative differences between subjects 48.2%), suggesting that the system is
suitable to capture such differences. No batch effect due to sampling date was observed, overall suggesting that the intra-subject
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variability measured for these series of aldehydes was biological rather than technical. High correlations found among the series
of aldehydes support this notion. Finally, recommendations for breath sampling and analysis for SESI-HRMS users are provided
with the aim of harmonizing procedures and improving future inter-laboratory comparisons.
Keywords Breath metabolomics . Fatty aldehydes . Secondary electrospray ionization high-resolution mass spectrometry .
Oxidative stress . Standardization procedures . Variability
Introduction
Mass spectrometry is a pivotal technique in clinical chemistry
laboratories and will continue its expansion to support clinical
decision-making [1]. One of such potential future applications
is the analysis of exhaled breath metabolites for clinical diag-
nosis and therapeutic monitoring [2]. However, such an en-
deavor requires standardized protocols, performed in multi-
center studies leading to conclusive evidence, before regula-
tory authorities can approve a clinical test. In this regard,
transitioning from promising research results to concrete clin-
ical applications proves to be a challenge, leading to few rou-
tinely used clinical breath tests [3].
A number of analytical techniques have emerged over the
last five decades, aiming to address this challenge, being the
earliest one gas chromatography-mass spectrometry (GC-MS)
[4, 5]. GC-MS and its improved modern variants such as
GC×GC-Time of flight remain to be the workhorse platform
capable of mapping the yet largely unknown breath metabo-
lome [6]. However, one important limitation of GC-MS is the
requirement of sample preparation, which leads to lengthy
analyses and poses at the same time additional difficulties to
standardize procedures and to preserve chemically
uncompromised breath specimens [7]. Since breath consti-
tutes a virtually unlimited source of information, real-time
techniques such as proton-transfer-reaction mass spectrometry
(PTR-MS) [8] and selected-ion flow-tube mass spectrometry
(SIFT-MS) [9] emerged to conveniently capture this informa-
tion. Such convenient online monitoring of exhaled metabo-
lites is obviously of great advantage. However, it comes at the
price of limited sensitivity―as no sample pre-concentration is
possible―and limited selectivity―as no chromatographic
separation prior to mass analysis is possible. A third real-
time mass spectrometric alternative is secondary electrospray
ionization-mass spectrometry (SESI-MS) [10]. In contrast to
PTR-MS and SIFT-MS, ionization of exhaled metabolites
takes place at atmospheric pressure in SESI-MS. The benefit
of doing so is twofold: (i) the ionization probability increases
with pressure [11] and (ii) it allows to conveniently interface
the ionization stage with virtually any pre-existing atmospher-
ic pressure ionization mass analyzer, including ultra-high-
resolution (> 100,000) MS such as Orbitrap. This results in
sensitive and selective, yet real-time, analysis of trace vapor
species. As a result, despite being the most recently proposed
mass spectrometric alternative for real-time gas analysis, it is
steadily gaining interest across different research groups [10,
12–26]. However, most of the published SESI-MS studies rely
on lab-built instrumentation, making it difficult to standardize
procedures for this technique. Following ongoing efforts to
standardize exhaled breath collection and subsequent analysis
for other analytical platforms [27–34], we present here a series
of instrumental developments aiming to standardize breath
analysis procedures and to provide recommendations for
SESI-HRMS users interested in breath analysis. To do so,
we characterized a series of new instrumentation with a focus
on a panel of three classes of exhaled aldehydes.
Material and methods
We investigated the exhaled breath composition of healthy sub-
jects by SESI-HRMS. The breath analysis platform consisted of
three main components. The first one was a newly developed
interface (Exhalion, FIT, Spain), which measures CO2 (%),
pressure drop (mbar), exhalation flow rate (L/min), and exhaled
volume (L) in real time to guide the exhalation maneuver.
Downstream, the exhaled breath is ionized in an ion source
(Super SESI, FIT, Spain). Ionized breath metabolites were then
analyzed in real time by a high-resolutionmass spectrometer (Q
Exactive Plus, Thermo Fisher Scientific, Germany). Figure 1 a
shows a picture of the breath analysis platform.
Exhalation maneuver monitoring and guiding
(Exhalion)
The breath interface Exhalion was constructed with the aim of
assisting in the control and reproducibility of exhalation maneu-
ver. Exhalion consists of the following elements: a disposable
standard antibacterial/antiviral medical grade filter. In this study,
commercially available spirometry filters (MicroGard™, Vyaire
Medical, USA; 3 cm ID; filters 99.98% of bacteria and 99.92%
of viruses) were used as a mouthpiece. Downstream, the filter is
connected to an autoclavable interface, housing a calibrated flow
restriction. Bymeasuring the pressure drop through the calibrated
restriction (range 0 to 20 mbar, accuracy 2.5%, precision 0.1
mbar), Exhalion determines the flow rate (range 0 to 15 L/min,
accuracy 2.5%), and total exhaled volume (the latter is automat-
ically estimated by detecting the onset of the exhalation and
integrating flow rate over time). Capnography data is measured
side-stream (range 0 to 20%, accuracy 5% of the reading), with
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an approximate flow rate of 0.5 L/min. Absolute pressure mea-
surement is also integrated and is used to compensate for the
effect of barometric variations on CO2 and flow readings. Time
and other parameters are measured at a rate of 1.5 Hz, and stored
in a text file. Finally, a main module, incorporating a touch
screen, a micro-computer, all sensors, and a dedicated firmware
to run autonomously, is used to process all the data from flow
restriction and capnograph in real time. All routines to seamlessly
calibrate the sensors are integrated into the firmware. The main
module and the flow restriction interface are connected with two
tubes (1/8^ OD, for CO2 and pressure measurement). Nafion
tubing was used to prevent condensation. The dead volume of
the side-stream tubing and the sensors was below 5 cm3, which
provides an upper limit for the CO2 reading delay of 0.5 s. The
total dead volume was dominated by the mouthpiece filter, as
Exhalion was designed to minimize this contribution. The
Exhalion device was connected downstream with the ionization
device (Super SESI).
Secondary electrospray ionization (Super SESI)
The Super SESI source was optimized for breath analysis and
integrates all components required to control the ionization of the
sample flow. A fraction of the total exhaled flow is passed to the
ionizer, which features a sampling line connected to an ionization
chamber whereby a nano-electrospray (0.1% ammonium for-
mate in water) ionizes the metabolites present in breath. We used
a 20-μm ID TaperTip (New Objective, USA) silica capillary
emitter. The Super SESI pressure was set to 1.3 bar to drive the
liquid through the capillary. The steady-state reading of the nano-
amperemeter indicated that a stable spray was formed (typically
130 nA). The sampling line temperature was set to 130 °C and
the ion chamber temperature was set to 90 °C. In addition, the
sampling line and the ionization chamber core were silica-coated
to minimize analyte adsorption onto the system walls. Super
SESI uses a flow of clean nitrogen (filtered through a built-in
activated charcoal filter) to sweep the ionizer when there is no
sample input. It was set to provide an excess of 0.4 L/min over
the flow ingested by the mass spectrometer (precise reading and
control of this is integrated into the Super SESI). The exhaust
mass flow controller was then set to 0.7 L/min so that the fraction
of breath entering the ionizer was fixed at 0.3 L/min regardless of
potential exhalation pressure fluctuations. The dead volume of
the sample line and the ionizer was approximately 10 cm3. At
this flow, the time required for breath to reach and sweep the
ionizer is 2 s.
High-resolution mass spectrometry (Q Exactive Plus)
The Super SESI source was directly coupled to the Q Exactive
Plus MS and was recognized as an ESI source (sheath gas flow
rate 60, auxiliary gas flow rate 2, spray voltage 3.5 kV, capillary
temperature 275 °C, and S-lens RF level 55.0). The MS was
operated directly via Q Exactive Tune software (version 2.9) in
a b
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Fig. 1 Real-time breath analysis using SESI-HRMS. a SESI-HRMS an-
alytical platform located in a clinical setting (University Children’s
Hospital Basel) dedicated for real-time breath analysis. The system fea-
tures three main elements: (i) exhalation interface, which provides feed-
back to the participants on the exhalationmaneuver; (ii) ion source, which
efficiently ionizes exhaled metabolites, and (iii) high-resolution mass
spectrometer. b Real-time analysis by simultaneous monitoring of CO2,
physical exhalation parameters (exhalation flow rate and exhaled vol-
ume), and relative intensities of three representative aldehydes from one
experiment. 13 consecutive exhalations within 20 min for one subject are
shown (see ESM Fig. S4 for zoomed-in view of the first exhalation).
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full MS mode (polarity positive, scan range 100 to 400 m/z,
microscans 4, ACG target 106, and maximum injection time
500 ms) with a resolution of 140,000 (at m/z 200). The MS
was externally calibrated on aweekly basis using a commercially
available calibration solution (Pierce™ Triple Quadrupole, ex-
tended mass range) and internally calibrated by enabling lock
masses (m/z 149.02332, 279.15909, 355.06993, 371.10123,
and 391.28429), which correspond to common backgroundmass
spectrometric contaminants [35, 36].
Subjects
Threemale and one female healthy subjects (33 ± 8 years, mean
± SD) were enrolled in the study, each subject provided at least
49 exhalations. All measurements were performed during
weekdays at any given time between 8 a.m. and 6 p.m. Fig.
S1 (see Electronic Supplementary Material, ESM) shows the
measurement scheduling distribution for all participants, indi-
cating no significant bias towards a specific time window for
any given subject. The sample size and number of replicates
resulted from estimating the within-subject standard deviation,
following the approach described by Bland and Altman [37].
Shortly, the precision with which one can estimate within-
subject standard deviation depends on both the number of sub-
jects and the number of observations per subject. Details are
described in the ESM (Table S1). The subjects provided
prolonged exhalations, whereby the subjects inspired to total
lung capacity and expired at a constant flow rate. This expira-
tion maneuver was repeated at least six consecutive times with
breaks of at least 10 s in-between replicate exhalations.
Typically, the total exhaled volume per exhalation was 3 L.
To guide the maneuver, the subjects could monitor in real time
their CO2 level, exhalation flow rate, and exhaled volume on
the Exhalion touch screen. Fig. S2 (see ESM) shows a picture
of how a subject would perform the breath test.
Data analysis
Raw data from the MS and Exhalion device were exported
and processed using MATLAB (version 2018a, MathWorks
Inc., USA). Briefly, raw MS data were converted into
mzXML file format using ProteoWizard’s msConvertGUI
[38]. Afterwards, each spectrum from all files was aligned
and calibrated using the RAFFT algorithm implemented in
MATLAB [39]. Then mspeaks and ksdensity functions of
MATLAB were used to appropriately pick and extract the
final feature list of 2,255 features. Molecular formulae were
generated based on the accurate mass by considering C, H, N,
and O [40]. A number of studies suggest using CO2- and
volume-controlled sampling maneuvers as a standardization
procedure [34, 41–44]. Following the recommendations to use
this physiological parameter to normalize breath analysis data,
we normalized signal intensities by considering exhalation
windows where the CO2 concentrations rose above 3%. In
particular, we computed the signal intensity for each of these
2,255 features during each exhalation by using the time cor-
responding to 3% or more of the CO2 signal (from Exhalion)
to define a single exhalation event. Finally, the integrated area
under the curve (AUC) for all features was normalized by the
exhaled volume in the exhalation (calculated by integrating
the flow over time in a particular exhalation from Exhalion
data). We will henceforth refer to this normalized AUC as
breath-signal.
For Fig. 2 and Figs. S6-S8 (see ESM), we first normalized
the breath-signal of metabolites from each experiment (con-
taining 6 exhalations) to the maximum. Then, normalized
breath-signals of metabolites were averaged across different
experiments to obtain the final Bmean normalized breath-
signal^ of metabolites for each subject along with their 95%
confidence interval (CI).
Intra-subject variability for each feature was estimated by
calculating the coefficient of variation (CV, expressed as per-
centage) of the replicate exhalations (this analysis led to
Table 1). Inter-subject variability was evaluated by performing
one-way analysis of variance (ANOVA; grouped by subjects),
followed by a multiple comparison (post hoc) test, using the
Bonferroni method, to determine whether pairs of group
means were significantly different (this analysis led to
Table 2).
Gas standard generation (ReGaS2)
To monitor the stability of the ionization, a reactive gas stan-
dard generator (ReGaS2) developed by the Swiss Federal
Institute of Metrology (METAS) [45], was used. This device
releases a flow with stable concentrations of trace gases and
can be used to standardize gas sensors. In our case, β-pinene
at a concentration of 92.7 ppb in air was used as target vapor
(carrier flow of 1 L/min and dilution flow of 0.5 L/min at an
oven temperature of 41 °C).
Results and discussion
Technical variability measured using β-pinene vapors
Before discussing the biological variability measured in hu-
man breath, we gauged the typical technical variability to be
expected for our SESI-HRMS system. In order to do so, we
infused a continuous stream of air seeded with 92.7 ppb of β-
pinene, simulating an exhalation maneuver. Upon injection of
the standard, the mass spectrum was dominated by the expect-
ed protonated β-pinene at m/z 137.1326 (C10H17), along with
some oxidized species (C10H15O and C10H17O2; ESM Fig.
S3). SESI-MS is known to detect trace species down to the
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sub-ppt range [22]. For this reason, and not surprisingly,
92.7 ppb of β-pinene nearly saturated the detector of the
Orbitrap mass analyzer. Because the dynamic range of our
mass analyzer is five orders of magnitude (signal intensity
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Fig. 2 Aldehydes show a subject-independent and molecule-dependent
exhalation pattern. Data shown is the mean normalized breath-signal with
errors bars representing 95% CIs for three selected aldehydes from four
subjects (denoted as S1–S4) in 104 experiments as a function of exhala-
tion number. Lighter species show a systematic decaying trend across
consecutive exhalations, which is subject independent.
Table 1 Intra-subject variability in the breath-signal for the series of aldehydes studied in this work. Themedian and IQR values of the CVs (expressed
as percentage) measured for the four subjects for the 27 aldehydes studied are listed; DBE double bond equivalent
m/z ([M + H]+) Metabolite Coefficient of variation (%)
S1 (N = 25) S2 (N = 29) S3 (N = 37) S4 (N = 13)
Formula
(M)
Name DBE Mass error
(ppm)
Median IQR Median IQR Median IQR Median IQR
143.1066 C8H14O2 4-Hydroxy-2-octenal 2 − 0.32 6.2 6.7 7.5 4.2 6.3 6.0 4.3 2.7
157.1223 C9H16O2 4-Hydroxy-2-nonenal 2 0.16 6.8 6.0 8.7 4.6 7.8 7.4 4.9 2.4
171.1379 C10H18O2 4-Hydroxy-2-decenal 2 − 0.15 7.3 5.3 7.5 4.8 7.3 5.8 4.3 2.2
185.1537 C11H20O2 4-Hydroxy-2-undecenal 2 0.30 6.8 4.8 7.5 4.2 6.9 6.5 4.4 3.8
199.1694 C12H22O2 4-Hydroxy-2-dodecenal 2 0.58 7.6 8.5 8.0 4.7 7.7 6.6 4.6 3.6
213.1851 C13H24O2 4-Hydroxy-2-tridecenal 2 0.68 7.6 6.7 7.9 4.7 6.5 5.5 4.7 2.5
227.2005 C14H26O2 4-Hydroxy-2-tetradecenal 2 − 0.11 5.6 4.5 7.2 3.9 6.6 5.6 5.5 4.0
241.2162 C15H28O2 4-Hydroxy-2-pentadecenal 2 − 0.11 4.8 5.1 6.1 5.0 6.1 3.8 5.7 3.2
255.2319 C16H30O2 4-Hydroxy-2-hexadecenal 2 − 0.02 6.2 5.0 5.1 5.0 6.0 5.8 7.1 3.4
127.1118 C8H14O 2-Octenal 2 0.07 6.5 3.8 6.3 4.2 7.3 8.5 7.4 6.5
141.1275 C9H16O 2-Nonenal 2 0.42 7.4 5.2 7.5 3.4 7.1 6.3 5.8 3.9
155.1429 C10H18O 2-Decenal 2 − 0.66 6.0 7.0 6.6 5.4 6.0 5.9 4.0 4.7
169.1587 C11H20O 2-Undecenal 2 − 0.01 6.6 7.0 8.1 4.2 7.4 5.6 5.7 5.3
183.1744 C12H22O 2-Dodecenal 2 0.49 6.7 4.9 7.7 5.2 6.9 6.3 5.4 2.2
197.1901 C13H24O 2-Tridecenal 2 0.56 6.5 7.3 7.0 3.5 7.5 7.0 5.5 4.6
211.2055 C14H26O 2-tetradecenal 2 − 0.53 7.5 5.7 7.8 4.9 6.8 5.9 7.1 4.9
225.2213 C15H28O 2-Pentadecenal 2 − 0.09 7.6 7.7 7.8 4.1 7.4 5.2 6.8 5.0
239.2369 C16H30O 2-Hexadecenal 2 − 0.05 8.3 7.0 12.8 12.2 8.4 7.2 8.0 8.4
141.0910 C8H12O2 4-Hydroxy-2,6-octadienal 3 0.25 5.4 5.8 7.3 3.6 5.7 4.8 4.5 3.0
155.1066 C9H14O2 4-Hydroxy-2,6-nonadienal 3 − 0.62 5.4 7.6 7.7 3.8 6.7 6.5 5.3 2.8
169.1223 C10H16O2 4-Hydroxy-2,6-dodecadienal 3 0.09 7.4 6.9 7.9 4.5 5.8 5.1 5.4 3.8
183.1380 C11H18O2 4-Hydroxy-2,6-undecadienal 3 0.46 7.1 6.3 7.8 3.5 7.7 5.7 4.5 3.0
197.1537 C12H20O2 4-Hydroxy-2,6-dodecadienal 3 0.58 7.6 5.5 7.7 4.5 5.3 4.3 4.8 3.0
211.1692 C13H22O2 4-Hydroxy-2,6-tridecadienal 3 − 0.41 7.0 7.3 7.7 5.0 6.0 5.6 5.1 4.3
225.1849 C14H24O2 4-Hydroxy-2,6-tetradecadienal 3 − 0.07 6.6 6.5 6.6 5.3 6.0 6.2 5.1 3.4
239.2005 C15H26O2 4-Hydroxy-2,6-pentadecadienal 3 − 0.11 7.4 6.6 11.7 13.5 5.8 4.7 5.3 6.2
253.2162 C16H28O2 4-Hydroxy-2,6-hexadecadienal 3 − 0.02 8.1 9.2 4.6 4.4 6.3 5.5 5.6 3.8
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104–109 a.u.), the limit of detection is expected to be at around
1 ppt, which is consistent with previous SESI-MS quantifica-
tion studies [46]. When we started the delivery of β-pinene,
the signal of the protonated analyte raised sharply to reach a
plateau. We measured the stability of the signal intensity de-
tection during 1 h. When the delivery of β-pinene was
stopped, the signal intensity dropped abruptly to baseline lev-
el, indicating no carryover effects, at least for this particular
compound (inset Fig. S3, see ESM). The CV of β-pinene
signal intensity during an hour of continuous delivery of the
vapor was found to be 2.3%. We therefore conclude that tech-
nical CVs within 3% are to be expected for our SESI-HRMS
platform.
Replicate exhalations: intra- and inter-subject
variability
In total, the four participants provided 648 exhalations (n =
171 for subject 1, n = 174 for subject 2, n = 225 for subject 3
and n = 78 for subject 4). These measurements were
subdivided into 104 single experiments (N = 25 for subject
1, N = 29 for subject 2, N = 37 for subject 3, and N = 13 for
subject 4) each containing 6 to 13 exhalations (replicates)
performed within 10 to 20 min. The aim was to examine the
variability across these replicates, considering that the techni-
cal variability, as mentioned above, was found to be in the
range of 3%. Figure 1 b shows one such representative exper-
iment whereby a subject provided 13 consecutive exhalations
during 19 min (ESM Fig. S4 shows a zoomed-in view of the
first exhalation, where the time traces can be inspected in
greater detail).
The vast majority of the features typically detected by
SESI-HRMS in human breath remain to be positively identi-
fied. However, over the last years, we have made a substantial
effort to systematically identify the molecular structure for
some of these metabolites by combining real-time breath
MS/MS analysis and UPLC-MS/MS analysis of exhaled
breath condensate [47–53]. Given the clinical importance of
aldehydes, as potential surrogates of oxidative stress [54–59],
we will concentrate in discussing our findings for a series of
three classes of fatty aldehydes [48]: 4-hydroxy-2-alkenals
(CxH2x – 2O2), 2-alkenals (CxH2x − 2O), and 4-hydroxy-2,6-
alkadienals (CxH2x − 4O2) with chain lengths ranging from
C8 to C16. These 27 representative aldehydes were used as
benchmarking metabolites. For reference, Fig. 1 b shows the
time traces of three such representative exhaled aldehydes and
Fig. S5 (see ESM) shows the time traces for the 27 aldehydes
of interest from the same experiment. The gray areas in Fig. 1
b and Fig. S4 (see ESM) represent the time windows whereby
CO2 levels were above 3%.
Visual inspection of CO2 and exhalation parameters from
Fig. 1b suggests a high repeatability across replicate measure-
ments. Indeed, computed mean ± SD for this particular
experiment yielded a CO2 level of 4.7 ± 0.1%, an exhalation
flow rate of 11.7 ± 0.3 L/min and an exhaled volume of 2.6 ±
0.1 L (i.e., excluding 0.5–0.6 L of breath not containing at
least 3% of CO2) for the considered windows. Median CVs
(IQRs) for CO2, exhalation flow rate, and exhaled volume
based on all 104 experiments were 3.2% (1.5%), 3.1%
(1.9%), and 5.0% (4.6%), respectively. The overall picture
for the aldehydes was somehow more complex. While 4-hy-
droxy-2,6-pentadecadienal in Fig. 1 b shows a relatively con-
stant behavior across all exhalations (akin to CO2), 2-
dodecenal drops over time during consecutive exhalations
and the decay is even more pronounced for 4-hydroxy-2-
nonenal, whose signal intensity decays by ~ 35% during the
first three exhalations, to then reach a steady state.
Interestingly, we observed this behavior systematically for
these particular molecules among all participants. Figure 2
shows the mean normalized breath-signal (see BMaterial and
methods^ for details) and the corresponding 95% CI from all
experiments for the four participants as a function of exhala-
tion number for the three selected representative compounds
shown in Fig. 1 b. It clearly shows that the dynamics for each
compound are subject independent and, interestingly, seem to
depend on the aldehyde chain length. For example, signal
intensity drops between the first and the sixth exhalation for
4-hydroxy-2-nonenal is around 50%, for 2-dodecenal the drop
is around 30%, whereas for 4-hydroxy-2,6-pentadecadienal
signal intensity remains stable (or even increases after the first
exhalation). This trend was systematically observed for all the
aldehydes from the three classes (ESM Figs. S6-S8).
Location within the respiratory system where the gas
exchange occurs may explain
the molecule-dependent exhalation traces
The signal intensity decaying behavior as a function of chain
length can be rationalized by the dependency with Ostwald
blood-air partition coefficient (λb:a), which is the most impor-
tant factor in determining the location within the respiratory
system where the gas exchange occurs [60]. Soluble gases
with λb:a > 100 exchange almost exclusively within the air-
ways (with the bronchial blood), whereas those with 10 < λb:a
< 100 exchange partially in the airways and in the alveoli, and
those with a λb:a < 10 nearly exclusively exchange in the
alveoli (with the pulmonary blood) [61]. Therefore, CO2
(λb:a = 3) exchanges in the alveoli [62]. Figure 1 b shows that
the CO2 level does not decrease as the participant provides
consecutive exhalations and this was the trend observed
across all measurements. The same trend is observed for the
longest aldehydes, which in turn have the lowest λb:a from the
series. The predicted λb:a by Kramer et al. [63] suggests that,
indeed, shorter aldehydes have a greater λb:a. For example, the
predicted λb:a for 2-hexenal was 111, therefore exchanges
almost exclusively in the airways. In contrast, 2-undecenal
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has a predicted λb:a = 39; hence, it exchanges partially in the
airways and in the alveoli. It is expected that even longer
aldehydes (> C14), such as those studied in this work, will
have a λb:a approaching the critical value of 10 (i.e., almost
exclusively exchanged in the alveoli). This trend can be ob-
served in Fig. S9 (see ESM), which shows predicted λb:a as a
function of the number of carbon atoms from the aldehydes,
based on data by Kramer et al. [63]. Thus, we hypothesize that
the longest aldehydes studied here (C14–C16) exchange exclu-
sively in the alveoli, and for this reason show a similar behav-
ior as CO2. In contrast, the smaller aldehydes exchange main-
ly in the airways, leading to a decrease during prolonged con-
secutive exhalations. For example, it has been estimated that
ethanol, which has a high blood solubility (λb:a = 1,803), can
show a 20% lower concentration than alveolar air after a com-
plete prolonged exhalation [62]. Reinforcing this idea, we
found that the signal intensity as a function of exhaled volume
during a single exhalation, varies significantly depending on
the aldehyde chain length and therefore on their λb:a. Figure 3
a displays signal intensity profiles of the aldehydes as a func-
tion of exhaled volume for a representative first and last ex-
halation in an experiment (same experiment as Fig. 1 b). It
clearly shows how the C9 metabolites reach a maximum in-
tensity at ~ 0.7 L to then decrease. In contrast, the exhalation
profile for the longest aldehydes (C12 and C15) tends to in-
crease systematically with exhaled volume (similarly to CO2
profiles). We hypothesize that, as the exhalation maneuver is
repeated, the net influx towards bronchial circulation exceeds
that outwards. Thus, the partial pressure cannot re-equilibrate
in the short lapse in-between exhalations, leading to a constant
non-linear decay across the repeated measurements. For 4-
hydroxy-2-dodecanal, we observed a deviation from the
decaying pattern (Fig. 3 a and ESM Fig. S5). The underlying
reason might be that this particular m/z channel is dominated
by an isomer of 4-hydroxy-2-dodecanal. It is important to note
at this point that this is a limitation of SESI-HRMS, as dis-
crimination of isomers is sacrificed by the possibility of
performing real-time analysis.
In order to further connect the theoretical explanation as to
why λb:a ultimately modulates the decay in signal intensity
due to gas exchange in the airways, Fig. 3 b (and ESM Fig.
S10) shows the experimental average breath-signal difference
between the last and first exhalation, as a function of predicted
λb:a. These λb:a values were estimated by fitting the λb:a for all
aldehydes reported by Kramer et al. [63] (ESM Fig. S9). It
reveals a clear trend, whereby for the longest chain (C16) the
difference tends to increase during the repeated measure-
ments. This is especially evident for 4-hydroxy-2-
hexadecenal (ESM Fig. S6). In contrast, as the chain length
decreases (and thus λb:a increases), the breath-signal differ-
ence decreases to finally reach a plateau of Δ −20% to
−40% at C11. The fact that this clear trend occurs in the tran-
sition boundaries between 10 < λb:a < 100 suggests that in-
deed this may be due to the different regions of the respiratory
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blood-to-air partition coefficient. a Exhalation profiles of short and long
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esis that the shorter aldehydes exchange mostly in the airways, while
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ated with a strongly decaying pattern (also see ESM Fig. S10, with x-axis
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system where these series of compounds exchange: from al-
veoli for C16 to airways for C8, with a mixed exchange situa-
tion for intermediate species. Further work is required to con-
firm this hypothesis and whether this could be further
exploited to infer physiological information of the respiratory
system, for example, complementing other tests such as the
multiple-breath washout test to measure abnormal ventilation
distribution between well- and poorly ventilated lung regions.
Despite that the first exhalationmay reflect more accurately
systemic concentrations for metabolites with high blood-air
partition coefficients, we recommend to sample at least ten
replicate exhalations and compute breath-signals considering
only the last three exhalations, thus capturing the steady state.
When doing so in the example shown in Fig. 1 b, the median
CV (IQR) for the 27 aldehydes was 4.1% (1.5%), which ap-
proaches the technical variability of ~ 3%measured with stan-
dard β-pinene vapors. However, for pediatric patients and
patients suffering from respiratory diseases, this may prove
difficult. For this reason, in order to determine an upper bound
of expected variability, we have evaluated here the variability
of breath metabolites across all subjects considering only six
exhalations and excluded the first three maneuvers to the
breath-signal for metabolites. When doing so, we found that
the median CV (IQR) for the aldehydes studied here was 6.7%
(5.5%). Table 1 lists the intra-subject CVs for the 27 aldehydes
studied here.
Flow dependency
Some studies indicate that the exhalation maneuver itself can
in some cases alter the metabolic profile, hence providing
misleading results [32]. For this reason, we further investigat-
ed whether the exhalation flow rate of our protocol had an
impact on the breath-signal of the exhaled metabolites. Flow
resistance of the device was as low as 3 mbar × min/L, mean ±
SD exhalation flow rates of all the experiments performed in
this study (N = 104) was 10.6 ± 0.9 L/min (ESM Fig. S11) and
typical exhaled volumes were in the order of 3 L (i.e., 15–20 s
of exhalation). It is important to note that this maneuver is far
less invasive and easy to perform than a classical spirometry,
whereby the forced expiratory volume in one second (FEV1)
can typically be 4 L in adults. This implies exhalation flow
rates around 25 times higher than the maneuver used in our
experiments. It has been shown that such forced expiration
maneuvers can lead to substantial changes in exhaled CO2
and other metabolites [32]. The fact that no significant chang-
es in the CO2 levels were observed suggests that the maneuver
does not induce hyperventilation [42]. In order to determine
whether there was any dependency with the exhalation flow
rate, we explored the impact of exhaling at two flow rates, one
at the lower end and another one at the upper end of the
distribution of exhalation flow rates measured for all partici-
pants (ESM Fig. S11). Figure 4 a shows the comparison of
two measurements from the same subject at a lower flow rate
(9.8 ± 0.1 L/min) and consecutively at a higher flow rate (12.0
± 0.3 L/min). Bland-Altman plot for log-transformed vari-
ables shows that the breath-signal of metabolites is indepen-
dent of the exhalation flow rate. The mean of log10(ratio) was
found to be − 0.09. As expected, only ~ 4% of low-intensity
ions lie outside the mean ± 1.96 × SD bands. We therefore
conclude that the range of flow rates between 9 and 12 L/min
are suitable for breath metabolomics using our particular
configuration.
Antibacterial/antiviral spirometry filter
Patient and operator safety and hygiene are crucial factors to
take into account in the clinics. For this reason, the interface
between the patient and the breath analysis platform is through
a disposable barrier filter, as the ones routinely used for pul-
monary function testing. This is a new element incorporated in
this device to allow for measuring patients with suspected
respiratory infectious diseases. Until now, our system featured
a mouthpiece filter used for alcohol breath tests, which would
not be suitable to investigate contagious respiratory diseases.
In a separate set of experiments, we examined whether these
aerosol filters may have an impact on the detectedmetabolites.
To do so, we compared the breath-signal of the same subject
exhaling through the filter and subsequently exhaling without
the filter. Figure 4 b shows the resulting comparison, repre-
sented as a Bland-Altman plot for log-transformed variables.
There appears to be a small bias towards lower intensities by
the use of the filter, as the mean of log10(ratio) was found to be
− 0.17. Moreover, only 4.6% of the signals fell outside the
mean ± 1.96 × SD boundaries. Globally, these results are
consistent with previous studies suggesting that SESI-MS
breath spectra using and removing aerosol filters look alike
[64]. We therefore conclude that, while the antibacterial/
antiviral filters incorporated in our system may partially sup-
press some signal intensities, they represent a good compro-
mise to protect the system and the operator from pathogens
and to preserve the quality of the mass spectral readout of
exhaled metabolites.
Instrumental time drift
Instrumental time drifts and batch effects are a common prob-
lem in untargeted metabolomics [65, 66]. This can be espe-
cially critical in clinical studies as patient recruitment typically
runs over several months/years. In order to assess whether our
system showed any significant batch effect due to the date of
measurement, we visualized our data using principal compo-
nents analysis (PCA). Figure 5 shows the resulting plot for the
first two components, whereby the labels on the left-hand side
correspond to a total of 17 measuring days spanning across
1 month. No clustering according to measuring day is evident,
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suggesting that the variance explained by these two compo-
nents (48.6% in total) cannot be attributed to a batch effect.
Note that no special cleaning procedures, apart from flushing
the ion source with hot nitrogen overnight, were performed
during this month of operation. In contrast, on the right-hand
side of Fig. 5, the same score plot is shown whereby the labels
now indicate the subject number. Grouping based on the sub-
ject number is much more evident. For example, subjects 1
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and 3 cluster together suggesting a significantly different ex-
haled metabolic phenotype than subjects 2 and 4. This is also
consistent with previous studies suggesting the existence of
stable individual-specific metabolic traits [67–69]. The same
picture emerged when we considered the 27 representative
aldehydes (ESM Fig. S12). In order to provide a more objec-
tive assessment of whether significant differences exist across
subjects for these metabolites, we conducted an ANOVA test
followed by post hoc multiple comparison using a Bonferroni
method (Table 2).
This univariate approach revealed significant differ-
ences in the breath-signal of exhaled aldehydes. Overall,
the median (IQR) relative difference between individuals
(considering only those p ≤ 0.05) was 48.2% (39.3%).
This is consistent with inter-subject variability in blood
concentrations for these particular compounds. For exam-
ple, Mak et al. [70] reported CVs for 4-hydroxy-nonenal
from eight healthy individuals of 95.8%. In our case,
mean differences between subject 1 and 2 were of
42.4% for this particular compound. It is therefore evident
that the inter-subject biological variability is greater than
intra-subject variability, and is consistent with the vari-
ability expected in blood levels.
Fatty aldehydes as surrogate markers of oxidative
stress
Fatty aldehydes were chosen as metabolite models for this
study as they are related to lipid peroxidation and oxidative
stress. Oxidative stress is the trigger for the production of fatty
aldehydes, such as 4-hydroxy-2-nonenal, in human metabo-
lism [71]. Abnormally elevated values (factor two to three as
compared to controls) of some of the aldehydes studied here
have been associated with pathologies such as congestive
heart failure [70]. Strong associations between series of me-
tabolites, i.e., in terms of correlations, might be an indication
for a common metabolic pathway, as already shown previous-
ly for series of omega-oxidation end-products of aliphatic fat-
ty acids [52, 72] and aminoacids [73]. In an attempt to visu-
alize whether an interplay between the different series of fatty
aldehydes may be captured by breath analysis, we computed
correlation coefficients across all measurements. A first indi-
cation suggesting that these metabolites are indeed metaboli-
cally connected is given by the fact that all of them showed
positive correlations (ESM Figs. S13-15). Thus, all measured
subjects had consistent (high or low) breath-signals for all 27
metabolites. One could argue that this might be an artifact as a
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result of different performance of the system during the dif-
ferent days (i.e., consistently high- or low-intensity mass spec-
tra). However, this can be ruled out as we found that these
aldehydes consistently correlated with each other, but not with
the rest of the over 2,000 features considered in the breath
mass spectra (ESM Fig. S16). Only around 2% of the pair-
wise correlations for all features correlated with r ≥ 0.85 with
the aldehydes. We therefore conclude that the observed asso-
ciations for these families of compounds should encode a
biological meaning. Figure 6 shows the resulting correlation
network for the aldehydes. Most of the aldehydes are indeed
linked with a mean ± SD degree of 4 ± 2 (r ≥ 0.85). This is to
be expected from the metabolic point of view, as aliphatic
aldehydes in humans are largely produced by a cascade of
catabolic metabolism of several lipids [71]. In particular,
peroxidative cleavage of polyunsaturated fatty acids by reac-
tive oxygen species is the mechanism behind a complete series
of aldehydes as those studied, including short- and medium-
chain aldehydes, or hydroxy-alkenals.
Conclusions
Summing up, we presented here a series of instrumental devel-
opments aiming to standardize sampling and analysis of ex-
pired metabolites by real-time SESI-HRMS. This analytical
platform was tested using a constant infusion of β-pinene va-
pors in the ppb range resulting in a technical variability within
3%.We then tested the system during a series of repeated breath
measurements from four healthy individuals. Real-time display
of CO2, exhalation flow rate, and exhaled volume to the sub-
jects during the exhalation maneuver enabled a variability for
these variables within 5%. We found no evidence that the ex-
halation maneuvers would induce hyperventilation, nor that the
exhalation flow rates and mouthpiece filter used would have
any significant impact on the quality of the metabolic breath
print.We also did not find any evidence of obvious batch effect.
However, despite these indications of exhalation maneuver
control and reproducibility, we observed a systematic decay in
the signal intensity of the shorter aldehydes across all measure-
ments for all subjects. This compound-specific and individual-
independent pattern has been rationalized as a result of the
different locations of the respiratory system where the alde-
hydes may exchange. We hypothesize that shorter aldehydes
exchange within the airways (with the bronchial blood), and
longer ones primarily in the alveoli (with the pulmonary blood).
Although the first exhalation may correlate better with systemic
aldehyde concentrations, we recommend the collection of at
least six replicate exhalations per subject and exclude the first
three from the analysis. Caution should be taken when
interpreting results from such measurements, especially for
shorter species. Taking into account these measures, we found
intra-subject variabilities is in general much lower than inter-
subject variability for the aldehydes studied (6.7% vs 48.2%).
Such inter-subject differences are consistent with reported var-
iability of such aldehydes in blood. Moreover, we found that all
27 aldehydes strongly positively correlated with each other,
which is to be expected due to their common metabolic origin
in humans. Overall, we conclude that this breath analysis plat-
form and procedures described herein meet the required stan-
dards to conduct breath metabolomics studies in multi-center
clinical studies. Further work to interrogate exhaled breath
using this analytical platform in two different clinical settings
is ongoing.
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